Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 3

Status

Unknown 5Completed 1

Sponsor Class

NIH 6INDUSTRY 1

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 6Thoracic 1Sarcoma 1Dermatologic 1Breast 1

Conditions

Pancreatic Neoplasms 3Stomach Neoplasms 1Sarcoma 1Rectal Neoplasms 1Leiomyosarcoma 1Gastrointestinal Stromal Tumors 1Esophageal Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Adenocarcinoma Of Esophagus 1

Interventions

Fluorouracil 126Leucovorin 90Oxaliplatin 82Specimen Handling 71Gemcitabine 61Magnetic Resonance Spectroscopy 55Irinotecan 55Biopsy 53Capecitabine 40Bevacizumab 40Radiotherapy 37Cisplatin 34Cetuximab 29Chemotherapy, Adjuvant 28Erlotinib Hydrochloride 26Neoadjuvant Therapy 21dehydroftorafur 20Cyclophosphamide 19Nivolumab 18Sorafenib 17Radiation 17Paclitaxel 17X-Rays 16Doxorubicin 16aldesleukin 14Immunoglobulin G 14Disulfides 14fludarabine 13Folfox protocol 13Carboplatin 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
NIH × rubitecan × Gastrointestinal × Clear all
NCT00005869 2013-12-04

Nitrocamptothecin Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer

National Cancer Institute (NCI)

Phase 3 Unknown
Gastrointestinal

Pancreatic Neoplasms

NCT00005870 2013-12-04

Nitrocamptothecin Compared With Other Chemotherapy in Treating Patients With Recurrent or Refractory Cancer of the Pancreas

National Cancer Institute (NCI)

Phase 3 Unknown
Gastrointestinal

Pancreatic Neoplasms

NCT00005871 2013-12-04

Nitrocamptothecin or Fluorouracil in Treating Patients With Recurrent or Refractory Pancreatic Cancer

National Cancer Institute (NCI)

Phase 3 Unknown
Gastrointestinal

Pancreatic Neoplasms

NCT00005874 2013-12-04

Nitrocamptothecin in Treating Patients With Soft Tissue Sarcomas

National Cancer Institute (NCI)

Phase 2 Completed
GastrointestinalSarcoma

Leiomyosarcoma, Sarcoma, Gastrointestinal Stromal Tumors

NCT00005876 2013-12-04

Nitrocamptothecin in Treating Patients With Locally Advanced or Metastatic Stomach Cancer That Cannot Be Removed During Surgery

National Cancer Institute (NCI)

Phase 2 Unknown
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Stomach Neoplasms

NCT00005877 2013-12-04

Nitrocamptothecin in Treating Patients With Advanced or Recurrent Colorectal Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡